Data gathered: October 17
Alternative Data for Quest Diagnostics
About Quest Diagnostics
Quest Diagnostics, Inc. engages in the provision fo diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses.
| Price | $148.96 |
| Target Price | Sign up |
| Volume | 582,140 |
| Market Cap | $16.6B |
| Year Range | $121.83 - $156.19 |
| Dividend Yield | 2.01% |
| PE Ratio | 20.1 |
| Analyst Rating | 18% buy |
| Earnings Date | October 22 '24 |
| Industry | Health Care Services |
In the news
 |
Exchange Traded Concepts LLC Increases Stock Position in Quest Diagnostics Incorporated (NYSE:DGX)October 17 - ETF Daily News |
Quest Diagnostics' Q4HE Initiative Advances Health Equity in Underserved Communities With Strategic Coalition Building and Targeted Funding in 2023October 16 - Finnhub |
|
|
Livforsakringsbolaget Skandia Omsesidigt Grows Stock Holdings in Quest Diagnostics Incorporated (NYSE:DGX)October 16 - ETF Daily News |
 |
Are Investors Undervaluing Quest Diagnostics (DGX) Right Now?October 15 - Yahoo |
YieldBoost Quest Diagnostics From 2% To 13.2% Using OptionsOctober 15 - Stock Options Channel |
|
Barclays Remains a Hold on Quest Diagnostics (DGX)October 15 - TipRanks |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '24 | 2.35B | 1.59B | 760M | 229M | 379M | 2.350 |
| Q1 '24 | 2.32B | 1.6B | 728M | 194M | 338M | 2.040 |
| Q4 '23 | 2.25B | 1.55B | 696M | 192M | 307M | 2.150 |
| Q3 '23 | 2.26B | 1.54B | 714M | 225M | 361M | 2.220 |
| Q2 '23 | 2.3B | 1.55B | 755M | 235M | 377M | 2.300 |
Insider Transactions View All
| PREVOZNIK MICHAEL E filed to sell 38,478 shares at $155. September 3 '24 |
| KUPPUSAMY KARTHIK filed to sell 11,459 shares at $153.3. August 29 '24 |
| DELANEY MARK E filed to sell 5,019 shares at $143.1. July 26 '24 |
| KUPPUSAMY KARTHIK filed to sell 13,435 shares at $140. May 1 '24 |
| PREVOZNIK MICHAEL E filed to sell 38,478 shares at $125.9. March 1 '24 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Earl Blumenauer Democrat |
May 4, 24 | Sell | $1K - $15K |
| Rohit Khanna Democrat |
Mar 6, 24 | Sell | $1K - $15K |
| Rohit Khanna Democrat |
Mar 6, 24 | Sell | $1K - $15K |
Read more about Quest Diagnostics (DGX) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
What is the Market Cap of Quest Diagnostics?
The Market Cap of Quest Diagnostics is $16.6B.
What is Quest Diagnostics' PE Ratio?
As of today, Quest Diagnostics' PE (Price to Earnings) ratio is 20.1.
When does Quest Diagnostics report earnings?
Quest Diagnostics will report its next earnings on October 22 '24.
What is the current stock price of Quest Diagnostics?
Currently, the price of one share of Quest Diagnostics stock is $148.96.
How can I analyze the DGX stock price chart for investment decisions?
The DGX stock price chart above provides a comprehensive visual representation of Quest Diagnostics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Quest Diagnostics shares. Our platform offers an up-to-date DGX stock price chart, along with technical data analysis and alternative data insights.
Does DGX offer dividends to its shareholders?
Yes, Quest Diagnostics (DGX) offers dividends to its shareholders, with a dividend yield of 2.01%. This dividend yield represents Quest Diagnostics' commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Quest Diagnostics in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Quest Diagnostics?
Some of the similar stocks of Quest Diagnostics are Abbott Laboratories, HCA Healthcare, Cardinal Health, Henry Schein, and Idexx Laboratories.
.